发明名称 QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.
摘要 <p>[PROBLEMS] To provide a compound having an excellent inhibitory effect on platelet aggregation. [MEANS FOR SOLVING PROBLEMS] Disclosed is a quinolone derivative having a lower alkyl, a cycloalkyl or the like at the 1-position; -N(R0)C(O)-lower alkylene-CO2R0, a lower alkylene-CO2R0, a lower alkenylene-CO2R0, -O-lower alkenylene-CO2R0, -O-(-lower alkylene which may be substituted by -CO2R0)-aryl, -O-lower alkenylene-CO2R0 (wherein R0 represents H or a lower alkyl) at the 3-position; a halogen at the 6-position; and an amino group substituted by a substituent having a cyclic structure at the 7-position, or a pharmaceutically acceptable salt thereof. It is found that the quinolone derivative has an excellent P2Y12Y-inhibiting effect. It is also found that the quinolone derivative has an excellent inhibitory effect on platelet aggregation. Therefore, the quinolone derivative or the pharmaceutically acceptable salt thereof is useful as a platelet aggregation inhibitor.</p>
申请公布号 MX2008011721(A) 申请公布日期 2008.11.14
申请号 MX20080011721 申请日期 2007.03.14
申请人 ASTELLAS PHARMA INC. 发明人 YUJI KOGA;TAKAO OKUDA;FUKUSHI HIRAYAMA;SUSUMU WATANUKI;HIROYUKI MORITOMO;JUN TAKASAKI;JIRO FUJIYASU;TAKASHI KAMIKUBO;MICHIHITO KAGEYAMA;TOSHIO UEMURA
分类号 C07D215/22;A61K31/47;A61K31/4709;A61K31/519;A61K31/5377;A61K31/662;A61K31/683;A61K31/695;A61P7/02;A61P9/00;A61P9/04;A61P9/10;A61P43/00;C07D215/56;C07D401/04;C07D401/12;C07D401/14;C07D405/04;C07D405/12;C07D409/12;C07D409/14;C07D413/12;C07D417/12;C07D417/14;C07D471/14;C07D487/04;C07D513/04;C07F7/18;C07F9/38;C07F9/40 主分类号 C07D215/22
代理机构 代理人
主权项
地址